[๐ข๐๐ป๐๐ฒ๐ฟ๐ป๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐๐๐๐ฅ๐ฎ๐ฌ๐ฎ๐ฐ] Brenus Pharma ๐ฝ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ฒ๐ฑ ๐๐ผ๐ฑ๐ฎ๐ ๐ฝ๐ฟ๐ผ๐บ๐ถ๐๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐ฟ๐ผ๐ฏ๐๐๐ ๐ฎ๐ป๐๐ถ-๐๐๐บ๐ผ๐ฟ ๐ฒ๐ณ๐ณ๐ถ๐ฐ๐ฎ๐ฐ๐ ๐ณ๐ผ๐ฟ ๐ฆ๐ง๐-๐ญ๐ฌ๐ญ๐ฌ, ๐ป๐ฒ๐ ๐ ๐ด๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ถ๐บ๐บ๐๐ป๐ผ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐, during the Association Cancer Research Annual meeting in San Diego.
This is validating our innovative approach to fight resistant hashtagtumors and highlighting STC-1010’s potential in clinical trials for treating colorectal cancer ; second leading cause of cancer-death worldwide.
An excellent consistency was observed with the 3 latest STC-1010 batches manufactured through standardized and scalable Brenusโ Stimulated-Tumor-Cell (STC) platform production.
๐โ๐๐ณ๐ณ๐ถ๐ฐ๐ฎ๐ฐ๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ฆ๐ง๐-๐ญ๐ฌ๐ญ๐ฌ ๐ฎ ๐ป๐ฒ๐ ๐ฎ๐น๐น๐ผ๐ด๐ฒ๐ป๐ฒ๐ถ๐ฐ ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐ถ๐ป ๐ฑ๐ถ๐ณ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ ๐ฐ๐ผ๐น๐ผ๐ฟ๐ฒ๐ฐ๐๐ฎ๐น ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐บ๐ผ๐ฑ๐ฒ๐น๐โย | Abstract 5003 https://lnkd.in/eibXkXpb
Meet George Alzeeb Innovation Manager – ๐๐ฉ๐ ๐ช๐ฏ ๐๐ฏ๐ค๐ฐ๐ญ๐ฐ๐จ๐บ
April 9, 2024, 9:00 AM – 12:30 PM (Pacific Daylight Time)
๐Section 39.
Poster available here : https://lnkd.in/ei55Wurf
STC doesnโt just fight cancer as it is today; it anticipates how cancer will evolve tomorrow, training the patient’s immune system to recognize and destroy tumors, even as they change. We are building a strong portfolio in solid tumors, leveraging our patented STC platform, leading the path to a new generation of immunotherapies to change a paradigm in oncology.
